SCHEMBL9587342

SCHEMBL9587342

NCCc1ccc(OC2CCCCC2)c(OC2CCCCC2)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 2/20 0.55
NUDT1 P36639 1/20 0.51
BACE1 P56817 1/20 0.51
KDM4E B2RXH2 1/20 0.49
ATM Q13315 1/20 0.49
PDE4B Q07343 2/20 0.45
RECQL P46063 1/20 0.45
PDE4A P27815 1/20 0.43
LOX P28300 1/20 0.43
LOXL2 Q9Y4K0 1/20 0.43
TSHR P16473 2/20 0.42
TAAR1 Q96RJ0 2/20 0.42
MAPK1 P28482 1/20 0.42
LMNA P02545 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
NFKB1 P19838 1/20 0.41
GLA P06280 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC2 Q92769 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9845122 0.98 CSNK2A1 (0.56) CSNK2A1NUDT1BACE1KDM4EATM
SCHEMBL9845095 0.95 CSNK2A1 (0.53) CSNK2A1NUDT1BACE1KDM4EATM
SCHEMBL9845094 0.92 KDM4E (0.53) CSNK2A1NUDT1BACE1KDM4EATM
SCHEMBL21255817 0.89 KDM4E (0.66) CSNK2A1KDM4EATMPDE4BRECQL
SCHEMBL7353001 0.89 KDM4E (0.66) CSNK2A1KDM4EATMPDE4BRECQL
Hydrochloric Acid SCHEMBL7355268 0.88 KDM4E (0.64) CSNK2A1KDM4EATMPDE4BRECQL
SCHEMBL20190365 0.86 CSNK2A1 (0.50) CSNK2A1NUDT1BACE1KDM4EATM
Hydrochloric Acid SCHEMBL20188074 0.84 CSNK2A1 (0.51) CSNK2A1NUDT1BACE1KDM4EATM
SCHEMBL7364533 0.81 CSNK2A1 (0.46) CSNK2A1NUDT1BACE1KDM4EATM
SCHEMBL7324772 0.81 PDE4B (0.55) CSNK2A1KDM4EATMPDE4BRECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5246949-A And lactic acid esters, treatment of hypotension and cardiac circulatory insufficiency SANSHO CO., LTD. (JP) 1993-09-21 US disclosed
EP-0431942-A2 Percutaneously absorbable pharmaceutical preparation containing dopamine derivative SANSHO CO., LTD. (JP) 1991-06-12 EP disclosed